#Antibodies

The Immunologist

eclecticbiotech

A thread on antibody-dependent enhancement (ADE) in #coronaviruses. While developing vaccines, treating patients with convalescent plasma, and considering immunity passports, we must first understand the complex role of antibodies in

Jen Heemstra

jenheemstra

You may have heard about the massive number of COVID-19 tests being run as colleges try to bring students back to campus. These “rapid” antigen tests provide results in 15

Prof Francois Balloux

BallouxFrancois

The news on #SARSCoV2 vaccines is highly encouraging. There are now 4 vaccines that seem safe and highly effective; two mRNA vaccines (Pfizer and Moderna) and two adenovirus ones (ChAdOx

Matteo Quartagno

stats_q

Results of massive (N=64000) nation-wide serosurvey in Italy are out. Available in Italian only, for the moment, so I'll translate a few highlights if you are interested.https://www.istat.it/it/archivio/246156 As little as

Dr. Angela Rasmussen

angie_rasmussen

This type of study is exactly what we need to assess the current state of broad quarantine measures in the US: combined serological testing and PCR testing for #SARSCoV2 #HCoV19

Lewis 'Horticultural Lad' Bartlett 🐝🍰

BeesAndBaking

I need people to understand that tweeting 'HAHA! antibodies rapidly fall! no immunity! no herd immunity strategy you fools'is not - even remotely - the 'got you' you think it

Alexandre Bolze

alexbolze

1/ Thread on the first 2 papers from the COVIDhge consortium (with my small contribution). The 2 studies show that genetic variants & auto-immunity to type 1 interferons explain 10-15%

Casey Ayers

caseyayers

You’ve probably seen the early word from Pfizer of 90% efficacy for the COVID-19 vaccine developed in coordination with BioNTech. I’d like to talk to you about it this morning,

Graham Neary

GrahamNeary

Why is Ireland locking down again? Look no further than our Covid-19 spreadsheet modellers.They are unshakeable in the belief that Covid-19 remains a deadly threat to the population. But as

Edward Nirenberg

ENirenberg

There's a thought I've had that's been bugging me and I'd love feedback from the pros on this point: I really don't like the term "natural immunity" to describe the

tiff 🍊

leaderkoya

thread on updates of my immuno prof giving us about the covid19 virus ill update on this thread:a prophylactic vaccine clinical trial in the process and launched in coming weeks.

eric hoyeon song

ericsongg

Part 2 of SARS-CoV-2 and its effects on the Brain with @ShelFarFar and @VirusesImmunity!https://www.biorxiv.org/content/10.1101/2020.09.11.293464v1**Highlights**-Characterization of COVID-19 neuroinflammation-Indirect evidence of SARS-CoV-2

🌈Trevor_Pott(BLM, $hero_sandwich_2020, π);

cakeis_not_alie

Progress!https://arstechnica.com/science/2020/05/early-tests-of-vaccine-for-covid-19-pass-peer-review-look-promising/ This is the first vaccine candidate that I'm actually excited about: using an adenovirus to trigger an immune response

Beͫvͣaͬnͨd

zorinaq

Today in NEJM, a new #covid19 study: https://www.nejm.org/doi/full/10.1056/NEJMoa2026116Let's see what they find about:- percentage who develop antibodies- antibody levels (not) changing over time- Infection Fatality Ratio (IFR)Spoiler:

Andy Slavitt 🇺🇸💉

ASlavitt

COVID Update August 24: The folly with the FDA and the White House should tell us a lot about the chaos, the bullying and priorities of this president. In case

Florian Krammer

florian_krammer

1) There is a lot of talk about decaying antibodies. I would like to walk you through a few findings about antibodies to SARS-CoV-2 that we put on medRxiv on